Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Moulière, Dineika Chandrananda, Anna Piskorz, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 466
Open Access | Times Cited: 834

Showing 1-25 of 834 citing articles:

Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano, Alessandro Leal, Jillian Phallen, et al.
Nature (2019) Vol. 570, Iss. 7761, pp. 385-389
Open Access | Times Cited: 1040
Liquid biopsy enters the clinic — implementation issues and future challenges
Michail Ignatiadis, George W. Sledge, Stefanie S. Jeffrey
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 297-312
Closed Access | Times Cited: 847
Integrating genomic features for non-invasive early lung cancer detection
Jacob J. Chabon, Emily G. Hamilton, David M. Kurtz, et al.
Nature (2020) Vol. 580, Iss. 7802, pp. 245-251
Open Access | Times Cited: 514
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon, Adam H. Buchanan, Isaac Kinde, et al.
Science (2020) Vol. 369, Iss. 6499
Open Access | Times Cited: 492
The emerging role of cell-free DNA as a molecular marker for cancer management
Abel J. Bronkhorst, Vida Ungerer, Stefan Holdenrieder
Biomolecular Detection and Quantification (2019) Vol. 17, pp. 100087-100087
Open Access | Times Cited: 477
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Laura Keller, Klaus Pantel
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 553-567
Closed Access | Times Cited: 461
Circulating tumor DNA and liquid biopsy in oncology
David W. Cescon, Scott V. Bratman, Steven M. Chan, et al.
Nature Cancer (2020) Vol. 1, Iss. 3, pp. 276-290
Closed Access | Times Cited: 446
Life and death of circulating cell-free DNA
Anatoli Kustanovich, Ruth Schwartz, Tamar Peretz, et al.
Cancer Biology & Therapy (2019) Vol. 20, Iss. 8, pp. 1057-1067
Open Access | Times Cited: 439
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Y. M. Dennis Lo, Diana Han, Peiyong Jiang, et al.
Science (2021) Vol. 372, Iss. 6538
Closed Access | Times Cited: 434
Artificial Intelligence in Cancer Research and Precision Medicine
Bhavneet Bhinder, Coryandar Gilvary, Neel S. Madhukar, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 900-915
Open Access | Times Cited: 427
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Javier Pascual, Gerhardt Attard, François‐Clément Bidard, et al.
Annals of Oncology (2022) Vol. 33, Iss. 8, pp. 750-768
Open Access | Times Cited: 378
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Laura Keller, Yassine Belloum, Harriet Wikman, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 2, pp. 345-358
Open Access | Times Cited: 327
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Asaf Zviran, Rafael Schulman, Minita Shah, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1114-1124
Open Access | Times Cited: 305
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
Arvind Dasari, Van K. Morris, Carmen J. Allegra, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 12, pp. 757-770
Open Access | Times Cited: 299
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Qianwei Ye, Sunbin Ling, Shusen Zheng, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 290
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour, Dominic G. Rothwell, Ged Brady, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 485-495
Open Access | Times Cited: 280
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
Everett J. Moding, Yufei Liu, Barzin Y. Nabet, et al.
Nature Cancer (2020) Vol. 1, Iss. 2, pp. 176-183
Open Access | Times Cited: 267
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol, Florent Moulière
Cancer Cell (2019) Vol. 36, Iss. 4, pp. 350-368
Open Access | Times Cited: 261
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
Melanie A. Krook, Julie W. Reeser, Gabrielle Ernst, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 5, pp. 880-892
Open Access | Times Cited: 249
The future of early cancer detection
Rebecca C. Fitzgerald, Antonis C. Antoniou, Ljiljana Fruk, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 666-677
Closed Access | Times Cited: 247
From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment
Kyle Swanson, Eric Q. Wu, Angela Zhang, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1772-1791
Closed Access | Times Cited: 244
Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation
Peiyong Jiang, Kun Sun, Wenlei Peng, et al.
Cancer Discovery (2020) Vol. 10, Iss. 5, pp. 664-673
Closed Access | Times Cited: 242
Circulating biomarkers for early detection and clinical management of colorectal cancer
María Marcuello, Veronika Vymetalková, Rui P. Neves, et al.
Molecular Aspects of Medicine (2019) Vol. 69, pp. 107-122
Open Access | Times Cited: 237
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
Hui Luo, Wei Wei, Ziyi Ye, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 5, pp. 482-500
Closed Access | Times Cited: 213
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
Peter Ulz, Samantha Perakis, Qing Zhou, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 211
Page 1 - Next Page

Scroll to top